Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jun 23:37:100818.
doi: 10.1016/j.gore.2021.100818. eCollection 2021 Aug.

Isolated splenic high-grade serous carcinoma: A case report

Affiliations
Case Reports

Isolated splenic high-grade serous carcinoma: A case report

Ralph Rogers et al. Gynecol Oncol Rep. .

Abstract

We present a unique case of high-grade serous carcinoma isolated to the spleen at the time of diagnosis, without any tumor present in the ovary, fallopian tubes, omentum or uterus, which was pathologically consistent with metastatic Mullerian carcinoma. Tumor sequencing with the MSK-IMPACT (Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets) multigene tumor panel test was performed, which revealed somatic mutations in PALB2 and in ARID1, as well as a TP53 hotspot mutation.

Keywords: ARID1 somatic mutation; High-grade serous carcinoma; PALB2 mutation; Pluripotent spleen cell; Splenic Mullerian carcinoma; TP53 hotspot mutation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
CT scan showing normal reproductive organs.
Fig. 2
Fig. 2
CT scan showing splenic mass.
Fig. 3
Fig. 3
PET-CT scan showing splenic mass.

References

    1. Chou C.K., Chou S.C. Serous cystadenocarcinoma of the spleen. Radiol. case reports. 2017;12(2):273–277. doi: 10.1016/j.radcr.2017.01.018. - DOI - PMC - PubMed
    1. Compérat, E., MD, Bardier-Dupas, A., MD, Camparo, P., MD, Capron, F., MD, and Charlotte, F., MD. (2007). Splenic Metastases: Clinicopathologic Presentation, Differential Diagnosis, and Pathogenesis. Archives of Pathology & Laboratory Medicine,131(6), 965-969. Retrieved November 28, 2020, from https://meridian.allenpress.com/aplm/article/131/6/965/62344/Splenic-Met.... - PubMed
    1. Dawoud, E., MD, PhD, Jansen, M., MD, FRCPath, and Al Shurbagy, D., MD, PhD., 2013. Solitary Splenic Metastasis from Ovarian Serous Adenocarcinoma: A Case Report. Austral-Asian Journal of Cancer,12(3), 175-180. Retrieved November 28, 2020, from http://www.australasiancancer.org/journal-article-view/solitary-splenic-....
    1. Faustman, D.L., Davis, M., 2010. Stem cells in the spleen: therapeutic potential for Sjogren's syndrome, type I diabetes, and other disorders. Int J Biochem Cell Biol. 42(10), 1576-9. doi: 10.1016/j.biocel.2010.06.012. Epub 2010 Jun 18. PMID: 20601088; PMCID: PMC4104595. - PMC - PubMed
    1. Furukawa N. Solitary splenic metastasis of ovarian cancer. Arch. Gynecol. Obstet. 2007;275:499–502. doi: 10.1007/s00404-006-0274-4. - DOI - PubMed

Publication types